Home » Topics » Regulatory » Patents

Patents
RSS

Compounds for treatment of seizure disorders described in Otsuka patent

Dec. 28, 2018

Glucose-lowering agents revealed in Daiichi Sankyo patent

Dec. 28, 2018

University of Pisa researchers describe GLP-1 receptor agonists

Dec. 28, 2018

Shenyang Research Institute of Chemical Industry patent reports IDO1 inhibitors

Dec. 28, 2018

ROMK inhibitors reported in Bristol-Myers Squibb patent

Dec. 27, 2018

Sunshine Lake Pharma reports agents for the treatment of HBV infections

Dec. 27, 2018

Shenzhen Salubris Pharmaceuticals describes DPP-IV inhibitors for diabetes

Dec. 27, 2018

NantBioScience reports high-affinity nerve growth factor receptor inhibitors

Dec. 27, 2018

Oryzon patents lysine-specific demethylase inhibitors

Dec. 27, 2018

Esteve Pharmaceuticals patent reports agents for the treatment of pain

Dec. 24, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...